Titelia

Holdings of China Universal Asset Management Co., Ltd.

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
451 in 15 countries
Top ten
35.1 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
201Workday Inc 5,992778.5K $
202Charter Communications, Inc. 3,562769K $
203Kraft Heinz Co/The 33,299748.9K $
204Philip Morris International Inc. 4,433738.3K $
205RTX Corp 3,818736.5K $
206Verisk Analytics Inc 3,880736.2K $
207Goldman Sachs Group Inc/The 854722.5K $
208Oracle Corp 4,909722.2K $
209Wells Fargo & Co 8,938711.6K $
210Ligand Pharmaceuticals Inc 3,539706.6K $
211Spyre Therapeutics Inc 13,938703K $
212JOYY Inc 12,000700.7K $
213UnitedHealth Group Inc 2,579697.9K $
214Amneal Pharmaceuticals Inc 55,834694K $
215Indivior Pharmaceuticals Inc 22,194676.5K $
216GE Vernova Inc 773675.1K $
217Crinetics Pharmaceuticals Inc 18,581674.9K $
218ACADIA Pharmaceuticals Inc 30,256673.5K $
219Structure Therapeutics Inc 13,824666.3K $
220Select Sector Spdr Trust 6,030657.1K $
221International Business Machines Corp. 2,662645.2K $
222STMicroelectronics NV 18,000621.9K $
223Verizon Communications Inc 12,006602.7K $
224ARM Holdings PLC 3,928594.2K $
225Travere Therapeutics Inc 19,825589K $
226Morgan Stanley 3,381556.4K $
227Vnet Group Inc 65,000545.4K $
228Disc Medicine Inc 8,372535.3K $
229Tarsus Pharmaceuticals Inc 7,552529.8K $
230Dyne Therapeutics Inc 29,219529.7K $
231Supernus Pharmaceuticals Inc 10,175525.9K $
232Ideaya Biosciences Inc 15,583519.2K $
233Arcutis Biotherapeutics Inc 22,011518.6K $
234Twist Bioscience Corp 10,880517K $
235Rambus Inc 6,000516.2K $
236Sarepta Therapeutics Inc 23,595513.4K $
237EyePoint Inc 39,691511.6K $
238Vera Therapeutics Inc 12,663509.4K $
239Tango Therapeutics Inc 23,900500K $
240Alumis Inc 22,436494.3K $
241Stoke Therapeutics Inc 15,136492.8K $
242Rubrik Inc 10,000489.7K $
243CoStar Group Inc 11,809476.4K $
244Natera Inc 2,330466K $
245Veracyte Inc 14,101454.2K $
246NIO Inc 75,000452.3K $
24710X Genomics Inc 20,882443.3K $
248Beam Therapeutics Inc 18,075430.7K $
249Intellia Therapeutics Inc 33,464429K $
250BioCryst Pharmaceuticals Inc 44,507423.7K $
251GRAIL Inc 8,168422.1K $
252Oruka Therapeutics Inc 8,591421.4K $
253Kodiak Sciences Inc 10,834413K $
254Enliven Therapeutics Inc 10,532412.9K $
255Agilent Technologies Inc 3,600411.2K $
256WeRide Inc 50,000404.5K $
257ON Semiconductor Corp 6,500402.5K $
258Adaptive Biotechnologies Corp 28,925401.5K $
259Corvus Pharmaceuticals Inc 27,155397.3K $
260Day One Biopharmaceuticals Inc 18,331393K $
261Trevi Therapeutics Inc 32,755390.8K $
262Hesai Group 20,000382.4K $
263ADMA Biologics Inc 42,263380.8K $
264Mineralys Therapeutics Inc 14,044380.5K $
265Rapport Therapeutics Inc 12,058377.3K $
266Repligen Corp 3,200377K $
267Design Therapeutics Inc 35,109373.6K $
268Elevance Health Inc 1,250365.9K $
269Syndax Pharmaceuticals Inc 15,652365.6K $
270Tyra Biosciences Inc 9,471362.7K $
271Ultragenyx Pharmaceutical Inc 17,148359.3K $
272Maze Therapeutics Inc 11,995358.1K $
273Agios Pharmaceuticals Inc 10,398351.8K $
274Zeta Global Holdings Corp 22,000350.2K $
275AnaptysBio Inc 6,164341.9K $
276Insulet Corp 1,600335.7K $
277Zymeworks Inc 13,280332.5K $
278Ocular Therapeutix Inc 38,631327.2K $
279Atlassian Corp 4,771325.6K $
280Immunocore Holdings PLC 10,783325.1K $
281Annexon Inc 57,683319.6K $
282Sionna Therapeutics Inc 7,920317.5K $
283Relay Therapeutics Inc 31,716315.6K $
284Quest Diagnostics Inc 1,600313.6K $
285Hilton Worldwide Holdings Inc 1,021310.5K $
286Genmab A/S 11,424306.5K $
287Innoviva Inc 13,145306.3K $
288ANI Pharmaceuticals Inc 3,978305.9K $
289Novo Nordisk A/S 8,100305.1K $
290Snowflake Inc 2,000301.6K $
291Astera Labs Inc 2,700295.9K $
292Vericel Corp 9,008289.8K $
293Nektar Therapeutics 4,000287.8K $
294Harmony Biosciences Holdings Inc 10,264287.5K $
295Septerna Inc 11,946287.1K $
296Recursion Pharmaceuticals Inc 92,624284.4K $
297Nurix Therapeutics Inc 18,250282.9K $
298IQVIA Holdings Inc 1,600272.9K $
299LEGEND BIOTECH CORP 14,978271K $
300Amylyx Pharmaceuticals Inc 19,488270.9K $

Download this table: CSV, JSON

Sector breakdown

  • Technology 34.8 %
  • Health care 13.7 %
  • Communication 10.7 %
  • Consumer discretionary 8.3 %
  • Consumer staples 4.5 %
  • Industrials 1.9 %
  • Financials 1.5 %
  • Utilities 0.6 %
  • Energy 0.5 %
  • Unattributed 23.4 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 96.1 %
  • Taiwan 0.9 %
  • Netherlands 0.7 %
  • Cayman Islands 0.6 %
  • United Kingdom 0.5 %
  • France 0.3 %
  • Denmark 0.2 %
  • Brazil 0.2 %
  • Germany 0.1 %
  • Hong Kong SAR China 0.1 %
  • Singapore 0.1 %
  • Spain 0.0 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States4131.2B $96.09 %
2Taiwan211.2M $0.89 %
3Netherlands39.4M $0.75 %
4Cayman Islands97.9M $0.62 %
5United Kingdom86.7M $0.53 %
6France53.8M $0.30 %
7Denmark33.1M $0.25 %
8Brazil12.5M $0.20 %
9Germany11.8M $0.14 %
10Hong Kong SAR China11.5M $0.12 %
11Singapore11.1M $0.08 %
12Spain1173.6K $0.01 %
Cite this page

Titelia. "Holdings of China Universal Asset Management Co., Ltd.". https://titelia.com/en/funds/US13F1906594